Crossmark

A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2

Crossref DOI link: https://doi.org/10.1039/D0RA09668G

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Damodharan, Kannan https://orcid.org/0000-0001-5334-5676
Arumugam, Gandarvakottai Senthilkumar

Ganesan, Suresh

Doble, Mukesh https://orcid.org/0000-0002-4335-0698
Thennarasu, Sathiah
Funding

Funding for this research was provided by:

Science and Engineering Research Board (PDF/2017/001743)
License Information

Version of Record valid from 2021-06-08
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Kannan Damodharan (ORCID)

: Mukesh Doble (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 13 November 2020; Accepted 14 January 2021; Version of Record published 8 June 2021

Document is current

Any future updates will be listed below